Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coretox (MT10107) vs Botox in Healthy Volunteers
NCT03796351Phase 1Completed
- Sponsor
- Medytox Inc.
- Start
- Sep 2012
- Primary completion
- Jan 2013
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of botulinum toxin type A in glabellar lines (2 arms), sponsored by Medytox Inc. Primary endpoint: Percentage change in CMAP M-wave amplitude in EDB muscle at 30 days. Started Sep 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT03796351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03796351.